Morepen Laboratories Ltd. (MOREPENLAB): Morepen Laboratories Share Price rises 5.65% to Rs 112.25
- September 16, 2026
- Posted by: Harsh Piplani
- Category: News
Morepen Laboratories Share Price rose today to Rs 112.25, up 5.65% from the previous close of Rs 106.25, with market capitalisation at Rs 6,353.52 crore. Morepen Laboratories Ltd. is in focus after the stock moved higher in the same session, while the supplied data does not establish a company-specific catalyst. The move makes Morepen Laboratories Share Price Today relevant for readers tracking Morepen Laboratories Stock News, valuation, and broader healthcare sector comparison on Univest. The stock opened at Rs 105.6, traded between Rs 97 and Rs 112.25, and ended at the session high, which is factual price action rather than a stated reason. Investors can monitor the next move alongside the company’s P/E, P/B, ROE, ROCE, EPS and book value for context, because those numbers help frame Morepen Laboratories Share Price in a broader financial lens.
Morepen Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 112.25 |
| Previous Close | Rs 106.25 |
| Today's Move | Rs 6 (+5.65%) |
| Open | Rs 105.6 |
| High | Rs 112.25 |
| Low | Rs 97 |
| Turnover | Rs 21.81 crore |
| Market Capitalisation | Rs 6,353.52 crore |
| Market Cap Category | Mid Cap |
Morepen Laboratories Ltd. (MOREPENLAB) rose to Rs 112.25 from the previous close of Rs 106.25, a move of Rs 6 or 5.65%. The stock opened at Rs 105.6, reached a high of Rs 112.25, recorded a low of Rs 97.
Morepen Laboratories Share Price Today rose by Rs 6 to Rs 112.25, compared with the previous close of Rs 106.25, reflecting a 5.65% share price gain in the session. The stock opened at Rs 105.6, touched an intraday low of Rs 97 and finished at Rs 112.25, which was also the day’s high. Turnover stood at Rs 21.81 crore. The supplied data confirms the price rise and the day’s trading range, but it does not establish a company-specific catalyst. In event-led coverage, that distinction matters: the move is real, the cause is not verified. For readers scanning Morepen Laboratories Stock News and Morepen Laboratories Share News, the main takeaway is the day’s upward price action and the fact that Morepen Laboratories Share Price closed at the top of its intraday band.
Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 6,353.52 crore |
| P/E Ratio | 41.43x |
| P/B Ratio | 4.47x |
| ROE | 7.96% |
| ROCE | 10.19% |
| EPS | Rs 2.56 |
| Book Value Per Share | Rs 23.78 |
| Dividend Yield | 0.19% |
Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 41.43x, P/B 4.47x, ROE 7.96%, ROCE 10.19%. These figures provide context only and are not a buy or sell signal.
Morepen Laboratories Ltd. has a market capitalisation of Rs 6353.52 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.43x, P/B at 4.47x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.96% and ROCE of 10.19%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.19%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.74x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 41.43x |
| Benchmark Median P/E | 31.74x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.29x to 683.37x |
| Company P/B Ratio | 4.47x |
| Benchmark Median P/B | 3.02x |
| Company ROE | 7.96% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 10.19% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 6,353.52 crore |
| Benchmark Median Market Cap | Rs 750.5 crore |
Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 41.43x, which is above the benchmark median of 31.74x, a difference of +30.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 7.96%, which is below the benchmark median of 11.78%, a difference of -32.43%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 10.19%, which is below the benchmark median of 13.65%, a difference of -25.35%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,41,957.5 | 36.4 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,47,576 | 83.41 | 13.81 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,233.01 | 84.58 | 20.55 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,670.55 | 24.29 | 4.07 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,272.68 | 32.62 | 3.13 | 11.83 | 16 |
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 41.43x compared with the displayed peer median of 36.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.96% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.19% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 6,353.52 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Morepen Laboratories
- Morepen Laboratories Share Price rose 5.65% today to Rs 112.25 after closing above the previous close of Rs 106.25.
- The stock traded between Rs 97 and Rs 112.25 and finished at the session high, which is clear price action for the day.
- Market capitalisation stands at Rs 6,353.52 crore, placing Morepen Laboratories Share Price within the listed healthcare universe in the supplied benchmark set.
- P/E of 41.43, P/B of 4.47, ROE of 7.96 and ROCE of 10.19 give Morepen Laboratories Fundamental Analysis a valuation-and-return backdrop.
- In the same-industry comparison, Morepen Laboratories Share Price sits above the benchmark median on P/E and P/B, while returns remain below the benchmark medians.
About Morepen Laboratories
Morepen Laboratories Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is part of the listed Indian pharmaceutical universe and is followed through Morepen Laboratories NSE and Morepen Laboratories BSE price tracking. In this article, Morepen Laboratories Share Price is analysed through the day’s move, valuation ratios, earnings quality and sector comparison rather than a speculative narrative. The supplied numbers show a business with market capitalisation of Rs 6,353.52 crore, EPS of Rs 2.56, book value of Rs 23.78 and dividend yield of 0.19%. For readers comparing Morepen Laboratories Stock News, Morepen Laboratories Latest News and Morepen Laboratories Company News, the company context is best understood through its place in healthcare, its valuation multiples and the return ratios disclosed in the supplied data. Univest presents this company overview so that Morepen Laboratories Share Price Today can be read alongside financial structure and sector context.
Track Morepen Laboratories Share Price on Univest
Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Morepen Laboratories Share Price rise today?
Ans. Morepen Laboratories Share Price rose 5.65% to Rs 112.25 in the session. The supplied data confirms the move, but it does not establish a company-specific catalyst, so the event should be read as verified price action.
What is Morepen Laboratories Share Price today?
Ans. Morepen Laboratories Share Price today is Rs 112.25. It moved up from the previous close of Rs 106.25 and ended the session at the day’s high, according to the supplied market data.
What is the market capitalisation of Morepen Laboratories?
Ans. Morepen Laboratories has a market capitalisation of Rs 6,353.52 crore. Market cap indicates company size, and it helps place Morepen Laboratories Share Price within the healthcare and pharmaceuticals universe. The company operates in the Healthcare sector.
How did Morepen Laboratories trade during the day?
Ans. The stock opened at Rs 105.6, hit a low of Rs 97 and reached a high of Rs 112.25 before closing at Rs 112.25. That sequence defines the day’s price action.
What valuation metrics support Morepen Laboratories Share Price analysis?
Ans. The key figures are P/E of 41.43, P/B of 4.47, EPS of Rs 2.56 and book value of Rs 23.78. These numbers help frame Morepen Laboratories Share Price in fundamental terms.
How does Morepen Laboratories compare with healthcare peers?
Ans. In the supplied peer set, Morepen Laboratories Share Price sits below larger peers on market cap and below all five peers on ROE and ROCE. Its P/E is also above Zydus and Cipla in the comparison set.
Is Morepen Laboratories part of the healthcare sector?
Ans. Yes. Morepen Laboratories operates in Healthcare, specifically Pharmaceuticals & Drugs. That sector context matters when comparing Morepen Laboratories Share Price with benchmarks, peers and industry averages. The stock belongs to the Healthcare sector.
What should investors monitor next for Morepen Laboratories Share Price?
Ans. Investors can monitor whether Morepen Laboratories Share Price holds near Rs 112.25, alongside valuation ratios, sector comparison and company updates. The supplied data supports monitoring, not prediction, so the next move remains factual only.
